RCE With FMT in the Treatment of Childhood Constipation

Status Completed

Clinical Trial Summary

Constipation is the most common complaint in childhood gastrointestinal disease, affecting an estimated 20% of the global children.The treatment strategies consist of diet control, behavioral intervention and oral and sometimes rectal laxatives. Given higher success rate and fewer side effects, the laxative PEG3350 has been considered the first choice in childhood constipation.However, effectiveness of PEG 3350 laxative is not lasting, and the use of PEG increases the risk of fecal incontinence. Additional treatment interventions are still necessary.Enema can act directly on the rectum and distal colon to quickly relieve symptoms of fecal impaction which is considered one of main source of intractable constipation. Children with fecal impaction who received enema had fewer fecal incontinence and diarrhea than children who received PEG. There have been lots of evidence that enema is effective in fecal impaction in children with functional constipation.But there are still cases of recurrences noted after enema. Fecal bacteria transplantation (FMT) is a new treatment method emerging in recent years, which is widely used in the treatment of functional gastrointestinal diseases. FMT has been proved to play a very prominent role in correcting intestinal flora disorders. By transplanting exogenous flora into the intestinal tract of patients, FMT can inhibit bacterial reproduction, regulate intestinal environment and cascade the body immunity, so as to achieve the therapeutic effect of disease. Retrograde colonic enema with FMT, an new method, provides the possibility for the treatment of childhood constipation. However, there is still a lack of evidence-based support for the treatment of childhood constipation by retrograde colonic enema with FMT. Therefore, we designed a randomized, controlled, double-blind clinical trial to confirm the efficacy and safety of retrograde colonic enema with FMT in the treatment of childhood constipation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05035784
Study type	Interventional
Source	Shengjing Hospital
Contact
Status	Completed
Phase	N/A
Start date	November 10, 2020
Completion date	May 13, 2022

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04436874` - Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease	N/A
Recruiting	`NCT03325855` - Fecal Microbiota Transplant National Registry
Completed	`NCT06162702` - Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)	N/A
Active, not recruiting	`NCT05607745` - Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study	N/A
Completed	`NCT05121285` - Distribution of FMT After Delivery by · Lower GI Endoscopy vs Enema With and Without Positioning of the Patient	N/A
Active, not recruiting	`NCT05917379` - The Safety and Efficacy of FMT in Patients With CID	Phase 1/Phase 2
Recruiting	`NCT02318147` - Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)	Phase 1
Completed	`NCT02318134` - Fecal Microbiota Transplantation for Pancreatitis	Phase 2
Active, not recruiting	`NCT04173208` - Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study	N/A
Terminated	`NCT04577729` - The IRMI-FMT Trial	N/A
Not yet recruiting	`NCT02435160` - The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis	Phase 2/Phase 3
Recruiting	`NCT04837313` - Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease With Constipation	N/A
Recruiting	`NCT04861649` - Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition	N/A
Withdrawn	`NCT04078581` - Profiling Fecal Samples for Selection of Donors of Feces	N/A
Recruiting	`NCT05821010` - Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis	Phase 2
Recruiting	`NCT05273255` - Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy	N/A
Not yet recruiting	`NCT05253222` - Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET	N/A
Recruiting	`NCT04285424` - FMT for Steroid Resistant Gut Acute GVHD	Early Phase 1
Withdrawn	`NCT03527056` - Pilot Study Using Oral Capsule FMT to Decolonize GI CRE	Early Phase 1
Recruiting	`NCT03016780` - Fecal Microbiota Transplantation for Ulcerative Colitis	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.